Medication info

JW 15% Dextrose Injection

Prescription medicationIntravenous injection
Ingredient · strength
Glucose›150g / 1000mL
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
Colorless and transparent liquid in a polypropylene, multi-layer film plastic container
Packaging
1000 milliliters/pack
Approval status
Active

MFDS item code 199700393 · Notified 1997.11.08 · Insurance code 644901941

Summary

Main use
Fluid and energy replacement (e.g., for hypoglycemia), treatment of heart disease (GIK), and treatment of drug and toxic substance poisoning
Who receives it
Adults
Adult administration
Adults: Inject 20~500mL intravenously per dose. The intravenous infusion rate should not exceed 0.5g/kg per hour, calculated as glucose. Use an appropriate amount to dissolve or dilute the injection. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Fluid and energy replacement (e.g., for hypoglycemia), treatment of heart disease (GIK), and treatment of drug and toxic substance poisoning

  • Hyperkalemia
  • circulatory collapse
  • hypoglycemia
  • heart disease
  • drug poisoning
  • toxin poisoning
View approved original text

This medication is used to supply energy required in cases of hyperkalemia, circulatory collapse, and hypoglycemia. It also aids in fluid and energy supply alongside various therapies for heart disease. It supports treatment in conditions resulting from drug or toxin poisoning.

How it is given

Adult administration

Adults: Inject 20~500mL intravenously per dose. The intravenous infusion rate should not exceed 0.5g/kg per hour, calculated as glucose. Use an appropriate amount to dissolve or dilute the injection. Adjust the dose as appropriate according to age and symptoms.

Precautions

This product contains dextrose, which can significantly increase the consumption of vitamin B1 in the body when administered intravenously. Thus, there is a risk of severe vitamin B1 deficiency and caution is advised. This product should not be administered to patients with certain conditions such as storage dehydration, fluid overload, hyperglycemia, acidosis, hypokalemia, hyperosmolar coma, glucose intolerance, anuria, hepatic coma, etc. Additionally, it should be avoided in patients with allergies to this product or its ingredients. Caution should be exercised in administering to patients who have a tendency for potassium, phosphate, magnesium deficiencies or those with hyponatremia, diabetes insipidus, renal failure, heart failure, severe malnutrition, thiamine deficiency, sepsis, severe dehydration, and shock states. Care is also needed in diabetic patients or those with blood dilution conditions. Rapid or large-scale administration can result in electrolyte imbalance or fluid overload, potentially leading to complications such as pulmonary edema or congestion. Moreover, the injection site may show inflammation, thrombosis, or pain, requiring monitoring. Long-term use may impact insulin secretion; thus, insulin may need to be co-administered for blood glucose control. During infusion, blood electrolyte and glucose levels should be regularly monitored, along with considerations for fluid balance. During pregnancy, safety for the fetus has not been established, and it should only be used when the therapeutic benefits outweigh the risks. Administering during labor poses risks of hyperglycemia and hypoglycemia for both mother and newborn and should be done with caution. Newborns, especially premature or low-birth-weight infants, are at high risk of hypoglycemia or hyperglycemia due to difficulties in blood glucose control, necessitating close monitoring. Hypoglycemia can lead to severe brain injury, and hyperglycemia can cause various complications. Elderly patients should be monitored more carefully due to decreased body function. In cases of overdose, symptoms of hyperglycemia or diabetes may occur, which should be managed with insulin. Subcutaneous administration is not recommended as it can cause electrolyte imbalance and local irritation. Unused solution should be discarded immediately after opening, and care should be taken during the injection process to prevent infection. At low temperatures, the solution should be warmed to body temperature before use, and careful administration is essential in cases of hypertonic solutions due to the risk of thrombophlebitis. Sudden withdrawal may cause hypoglycemia, so it is advisable to discontinue gradually. When administered simultaneously with blood, agglutination reactions may occur; thus, they should be avoided. When mixed with other drugs, one should be fully aware of potential chemical and physical side effects and observe carefully. After mixing, it should be used immediately, and multiple containers should not be connected in series to avoid the risk of air embolism due to air in the container.

Side effects

  • Electrolyte loss
  • elevated bilirubin levels
  • elevated lactate levels
  • hypokalemia
  • hyperosmolar coma
  • acidosis
  • dehydration
  • hyperosmolarity
  • polyuria
  • hypervolemia or hyperosmolar status
Show 11 more
  • fluid and electrolyte imbalance
  • congestion
  • pulmonary edema
  • hyperglycemia
  • renal loss
  • fever
  • phlebitis
  • thrombosis
  • blood leakage
  • injection site pain
  • uremia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture. This ensures that the effectiveness of the medication remains intact and safe for use.

Appearance and packaging

Appearance

Colorless and transparent liquid in a polypropylene, multi-layer film plastic container

Package unit

1000 milliliters/pack

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.